文献速递慢阻肺

肺功能阈值与呼吸道症状能否识别慢阻肺前期?前瞻性人群队列研究

Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-based Cohort Study.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

基于塔斯马尼亚纵向健康研究人群队列,在45岁时无慢阻肺的801名参与者中评估肺功能阈值和呼吸道症状对53岁时慢阻肺发病的识别能力。结果显示支气管舒张前FEV1/FVC z评分低于-1.264(最低第10百分位)者8年随访期间慢阻肺风险增加36倍(RR 35.8,95%CI 8.88-144),敏感度88%、特异度87%。呼吸道症状、支气管舒张后肺功能、弥散功能和静态肺容量未改善单独使用支气管舒张前FEV1/FVC的分类效果。

要点

  • 支气管舒张前FEV1/FVC z评分低于-1.264(第10百分位)可识别慢阻肺高危人群。
  • 该阈值下8年慢阻肺风险增加36倍,敏感度88%、特异度87%。
  • 呼吸道症状及其他肺功能指标未优于单独使用支气管舒张前FEV1/FVC。

核心结论

  • 研究支持将支气管舒张前肺量计纳入慢阻肺前期的生理学定义。
  • 支气管舒张前FEV1/FVC在第10百分位可准确识别社区人群中慢阻肺高危个体。

研究设计与样本

  • 塔斯马尼亚纵向健康研究为人群队列,1968年7岁时首次研究。
  • 45岁时子组测量呼吸道症状、支气管舒张前后肺量计、弥散功能和静态肺容量,53岁时评估慢阻肺发病率。
  • 801名45岁时无慢阻肺的参与者纳入分析。
  • 各肺功能指标z评分基于全球肺功能倡议参考值计算,最优阈值由未加权Youden指数确定。

主要发现

  • 53岁时慢阻肺发病的最优阈值为支气管舒张前FEV1/FVC z评分低于-1.264,对应最低第10百分位。
  • 低于该阈值者8年随访期间慢阻肺风险比为35.8(95%CI 8.88-144),风险差为16.4%(95%CI 3.7-67.4)。
  • 敏感度88%,特异度87%,阳性似然比6.79,阴性似然比0.14。
  • 呼吸道症状、支气管舒张后肺量计、弥散功能和静态肺容量未改善单独使用支气管舒张前FEV1/FVC的分类效果。

关键数值与推荐

  • 支气管舒张前FEV1/FVC z评分低于-1.264(最低第10百分位)为识别慢阻肺发病的最优阈值。
  • 该阈值下8年随访慢阻肺风险比35.8(95%CI 8.88-144),风险差16.4%(95%CI 3.7-67.4)。
  • 敏感度88%,特异度87%,阳性似然比6.79,阴性似然比0.14。

临床怎么用

  • 在社区人群中可考虑使用支气管舒张前FEV1/FVC z评分低于-1.264识别慢阻肺高危中年人。
  • 呼吸道症状及其他肺功能指标不优于单独支气管舒张前FEV1/FVC,不应替代其用于风险分层。

局限性

  • 研究人群为塔斯马尼亚纵向健康研究队列,外推至其他人群需谨慎。
  • 研究聚焦中年成人,未验证其他年龄组。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: The term "pre-chronic obstructive pulmonary disease" ("pre-COPD") refers to individuals at high risk of developing COPD who do not meet conventional spirometric criteria for airflow obstruction. New approaches to identifying these individuals are needed, particularly in younger populations. Objectives: To determine whether lung function thresholds and respiratory symptoms can be used to identify individuals at risk of developing COPD. Methods: The Tasmanian Longitudinal Health Study comprises a population-based cohort first studied in 1968 (at age 7 yr). Respiratory symptoms, pre- and post-bronchodilator (BD) spirometry, diffusing capacity, and static lung volumes were measured in a subgroup at age 45, and the incidence of COPD was assessed at age 53. For each lung function measure, z-scores were calculated using Global Lung Function Initiative references. The optimal threshold for best discrimination of COPD incidence was determined by the unweighted Youden index. Measurements and Main Results: Among 801 participants who did not have COPD at age 45, the optimal threshold for COPD incidence by age 53 was pre-BD FEV1/FVC z-score less than -1.264, corresponding to the lowest 10th percentile. Those below this threshold had a 36-fold increased risk of developing COPD over an 8-year follow-up period (risk ratio, 35.8; 95% confidence interval, 8.88 to 144), corresponding to a risk difference of 16.4% (95% confidence interval, 3.7 to 67.4). The sensitivity was 88%, and the specificity was 87%. Positive and negative likelihood ratios were 6.79 and 0.14, respectively. Respiratory symptoms, post-BD spirometry, diffusing capacity, and static lung volumes did not improve on the classification achieved by pre-BD FEV1/FVC alone. Conclusions: This is the first study, to our knowledge, to evaluate the discriminatory accuracy of spirometry, diffusing capacity, and static lung volume thresholds for COPD incidence in middle-aged adults. Our findings support the inclusion of pre-BD spirometry in the physiological definition of pre-COPD and indicate that pre-BD FEV1/FVC at the 10th percentile accurately identifies individuals at high risk of developing COPD in community-based settings.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Tan DJ, Lodge CJ, Walters EH, et al. Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-based Cohort Study. Am J Respir Crit Care Med. 2024. PMID: 38236192. doi:10.1164/rccm.202212-2330OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。